Greater adherence to lifestyle recommendations associated with lower cancer risk
Greater adherence to the WCRF/AICR cancer prevention recommendations — which encourage a healthy lifestyle — is associated with lower cancer risk. …
Genomic study links cannabis abuse to multiple health problems
An analysis of the genomes of more than 1 million people has shed light on the underlying biology of cannabis use disorder and associated health risks. …
Multinational study confirms association between CT scans in young people and increased risk of blood cancers
A multinational study of almost one million individuals confirms a strong and clear association between exposure to radiation from CT scans in young people and an increased risk of blood cancers. …
Study reveals genetic chain reaction that drives the spread of prostate cancer
New research identifies gene responsible for the molecular domino effect driving prostate cancer growth and metastasis. …
New strategy attacks treatment-resistant lymphomas
A combination of approved chemotherapies, one of which targets a DNA repair-facilitating mechanism, could help treat patients with treatment-resistant lymphomas. …
Colorectal cancer: aspirin activates protective genes
Study identifies the mechanism by which aspirin inhibits colorectal cancer progression. …
Epigenetic drugs could boost cancer immunotherapy
The induction of neoantigens by epigenetic drugs could help increase the efficacy of cancer immunotherapy. …
Certain per- and polyfluoroalkyl “forever chemicals” identified as potential risk factor for thyroid cancer
New findings suggest a link between certain per- and polyfluoroalkyl substances (PFAS) and an increased risk for thyroid cancer. …
Promising new options for treating aggressive prostate cancer
Results of a phase 3 clinical trial point to two promising new treatment options for men with recurrent prostate cancer. …
Researchers develop blood test for early-stage ovarian cancer
A new study on human tissue and plasma shows a liquid biopsy may distinguish between ovarian cancer and benign pelvic masses with up to 91% accuracy. …
End of content
End of content
